מדינה: ניו זילנד
שפה: אנגלית
מקור: Medsafe (Medicines Safety Authority)
Fexofenadine hydrochloride 180mg;
Teva Pharma (New Zealand) Limited
Fexofenadine hydrochloride 180 mg
180 mg
Tablet
Active: Fexofenadine hydrochloride 180mg Excipient: Croscarmellose sodium Lactose monohydrate Magnesium stearate Maize starch Microcrystalline cellulose Opacode Povidone Purified talc Purified water Sodium laurilsulfate
Blister pack, PVC / PE / PVDC / Al foil blister, 10 tablets
Pharmacy only
Pharmacy only
Virupaksha Organics Pvt. Ltd.
Package - Contents - Shelf Life: Blister pack, PVC / PE / PVDC / Al foil blister - 10 tablets - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC / PE / PVDC / Al foil blister - 30 tablets - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC / PE / PVDC / Al foil blister - 100 tablets - 36 months from date of manufacture stored at or below 25°C
2007-10-11
CONSUMER MEDICINE INFORMATION FEXOFAST Fexofenadine hydrochloride 120 mg and 180 mg Tablets WHAT IS IN THIS LEAFLET This leaflet answers some common questions about FEXOFAST. It does not contain all of the available information. It does not take the place of talking to your pharmacist or doctor. All medicines have benefits and risks. Your pharmacist or doctor has weighed the risks of you taking FEXOFAST against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR PHARMACIST OR DOCTOR. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT FEXOFAST IS USED FOR FEXOFAST contains the active ingredient fexofenadine hydrochloride. This medicine belongs to a group of medicines called antihistamines. Antihistamines help reduce allergic symptoms by preventing the effects of a substance called histamine. Histamine is produced by the body in response to foreign substances that the body is allergic to. FEXOFAST relieves the symptoms of seasonal allergic rhinitis (occurs at particular times of the year; commonly known as hayfever) and perennial allergic rhinitis (occurs at any time of the year; caused by house dust, mites or pets). These symptoms include sneezing bouts, runny or itchy and sometimes blocked nose, itchy red or watery eyes, itchy palate, and itchy or blocked ears. FEXOFAST 180 is also used to relieve the symptoms of urticaria, otherwise known as hives or itchy rash. FEXOFAST is a non-sedating antihistamine, which means it has been shown to not cause drowsiness. FEXOFAST is not recommended for use in children under 12 years of age. There is no evidence that FEXOFAST is addictive. BEFORE YOU TAKE FEXOFAST _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE FEXOFAST IF YOU ARE ALLERGIC TO קרא את המסמך השלם
1 FEXOFAST Fexofenadine Tablets PRESENTATION FEXOFAST 120 Peach coloured, circular, biconvex film coated tablets, embossed with 'F' on one side and plain on the other side. Each tablet contains 120 mg of fexofenadine hydrochloride. FEXOFAST 180 Peach coloured, capsule shaped, biconvex film coated tablets, embossed with 'F' on one side and plain on the other side. Each tablet contains 180 mg of fexofenadine hydrochloride. USES ACTIONS Fexofenadine is the carboxylic acid metabolite of terfenadine and largely responsible for the antihistaminic effects of terfenadine. Fexofenadine is an orally active non-sedating H 1 -receptor antagonist and is effective for the relief of symptoms associated with allergic rhinitis (sneezing, rhinorrhea, pruritus and lacrimation) and urticaria. The antihistaminic effects of fexofenadine have been demonstrated in animal systems both _in vitro_ and _in vivo_. Oral administration of fexofenadine to guinea pigs indicated that fexofenadine antagonised histamine induced skin weals in a dose dependent manner. Fexofenadine and terfenadine antagonised the contractile effects of histamine in the guinea pig ileum _in _ _vitro_. In this model, fexofenadine was found to be a more selective histamine antagonist than terfenadine. Fexofenadine inhibited antigen induced bronchospasm in sensitised guinea pigs and at high doses (> 100 times higher than those required for antihistaminic activity) inhibited histamine release from peritoneal mast cells of the rat. In laboratory animals, no anticholinergic or α 1 -adrenergic receptor blocking effects were observed. Radiolabell קרא את המסמך השלם